Impact of SARS-CoV-2 pandemic on vascular liver diseases

Vascular liver diseases (VLD) are represented mainly by portosinusoidal vascular disease (PSVD), non-cirrhotic splanchnic vein thrombosis (SVT) and Budd Chiari syndrome (BCS). It is unknown whether patients with VLD constitute a high-risk population for complications and greater COVID-19-related mortality from SARS-CoV-2 infection. Our objective was to assess the prevalence and severity of SARS-CoV-2 infection among patients with VLD, as well as to assess its impact on hepatic decompensation and survival.

Source: Clinical Gastroenterology and Hepatology - December 26, 2021 Category: Gastroenterology Authors: A. Baiges, E. Cerda, C. Amicone, L. T éllez, E. Alvarado-Tapias, A. Puente, J.I. Fortea, E. Llop, F. Rocha, L. Orts, O. Ros-Fargas, P. Vizcarra, K. Zekrini, Y. Ould Amara, G. Touati, N. Jimenez, M.J. Serrano, A. Falgà, M. Magaz, P. Olivas, F. Betancourt Source Type: research